《全日总结》恒指升164点 小米药明生物扬 吉利挫逾6%
人行今天开展7,000亿人币一年期MLF操作，内地股市上涨，港股今日跟随造好。恒指高开29点後升幅扩大，最多升405点曾高见25,588点，尾市升幅收窄，全日升164点或0.7%，收25,347点；国指升119点或1.2%，收10,385点；恒生科技指数升36点或0.5%，收7,075点。大市全日成交总额1,287.57亿元，沪、深港通南下交易录得净流入金额分别为16.8亿及22.44亿元人民币。
内险股领涨，国寿(02628.HK)升5.2%重上20元，为升幅最大蓝筹。中国太平(00966.HK)升5.2%。中国平安(02318.HK)升2.8%报85.45元。新华保险(01336.HK)升7.3%，人保(01339.HK)及太保(02601.HK)各升3%。
建行(00939.HK)、工行(01398.HK)、中行(03988.HK)及农行(01288.HK)各升1%至1.4%，招行(03968.HK)升4.7%。中资券商股向上，中信建投(06066.HK)及光大证券(06178.HK)各升6.9%及7.2%，中金公司(03908.HK)、中信证券(06030.HK)、申万宏源(06806.HK)、海通证券(06837.HK)、中国银河(06881.HK)及华泰证券(06886.HK)各升3.9%至5.3%。
恒指公司上周五(14日)公布更换成分股。被剔出蓝筹股的中国旺旺(00151.HK)及信置(00083.HK)各跌3.2%及3.8%，神华(01088.HK)随其他煤炭股升1.2%。获纳入蓝筹的小米(01810.HK)及药明生物(02269.HK)各升5.6%及4.7%。同被纳入蓝筹的阿里巴巴(09988.HK)遭淡马锡减持，股价跌1.6%报242.8元。未能晋身蓝筹的美团(03690.HK)全日股价跌0.7%报218.2元。
其他蓝筹及国指股方面，腾讯(00700.HK)跌0.4%报504.5元，汇控(00005.HK)跌0.3%报34.6元，港交所(00388.HK)升2.2%报376.6元，友邦(01299.HK)升0.2%报75.25元。吉利(00175.HK)半年少赚43%及下调全年销量预测，股价跌6.3%，为跌幅最大蓝筹及国指成分股。
5G概念股现炒作，中兴(00763.HK)及京信通信(02342.HK)各升4%及3.8%，长飞光纤光缆(06869.HK)升2%。手机相关股方面，丘钛(01478.HK)半年多赚86%，股价急升13.3%。比亚迪电子(00285.HK)升7.1%。晶片股中芯(00981.HK)及华虹半导体(01347.HK)各跌1.3%及1.5%。
内房股方面，恒大(03333.HK)发盈警，股价挫11.4%。世茂(00813.HK)及龙湖(00960.HK)各升4.1%及2%。金银股再受捧，中国黄金国际(02099.HK)升9.6%，中国白银(00815.HK)、山东黄金(01787.HK)及紫金(02899.HK)各升4.3%至4.4%，招金(01818.HK)升2.4%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
